Skip to main content
SpringerLink
Log in

Using 18F-FDG PET/CT to Diagnose and Treat Non-small Cell Lung Cancer

  • Chapter
  • First Online:
Nuclear Medicine in Oncology

  • 893 Accesses

Abstract

Primary lung cancer is the leading cause of cancer-related death worldwide and is the most incident cancer, causing about 1.37 million deaths per year globally [1]. In China, both the incidence and the mortality rates of lung cancer also rank first, and the incidence of lung cancer is higher in males than in females, with a sex ratio (male/female) of 3–5:1. In recent years, the incidence of lung cancer in females has increased markedly; most of these patients are older than 40 years. In urban settings, both the incidence and mortality rates of lung cancer are slightly higher than in rural settings, whereas an opposite result was observed after age standardization. Most lung cancer is derived from the epithelium of the tunica mucosa bronchiorum. Lung cancer is classified as non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). NSCLC is the most common type, accounting for ~85% of lung cancers, including squamous carcinoma (SQCC), adenocarcinoma (ADC), and large cell carcinoma. The incidence of SCLC has been decreasing for decades [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, Czernin J, Schiepers C (2007) Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 48:214–220

    PubMed  Google Scholar 

  3. Herder GJ, Golding RP, Hoekstra OS, Comans EF, Teule GJ, Postmus PE, Smit EF (2004) The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 31:1231–1236

    Article  PubMed  Google Scholar 

  4. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K (2004) Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 45:19–27

    Article  PubMed  Google Scholar 

  5. Lin YY, Chen JH, Ding HJ, Liang JA, Yeh JJ, Kao CH (2012) Potential value of dual-time-point (1)(8)F-FDG PET compared with initial single-time-point imaging in differentiating malignant from benign pulmonary nodules: a systematic review and meta-analysis. Nucl Med Commun 33:1011–1018

    Article  PubMed  Google Scholar 

  6. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

    Article  CAS  PubMed  Google Scholar 

  7. Delea T, Langer C, McKiernan J, Liss M, Edelsberg J, Brandman J, Sung J, Raut M, Oster G (2004) The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology 67:390–396

    Article  PubMed  Google Scholar 

  8. Ulas A, Bilici A, Durnali A, Tokluoglu S, Akinci S, Silay K, Oksuzoglu B, Alkis N (2016) Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases. Tumour Biol 37:1131–1140

    Article  CAS  PubMed  Google Scholar 

  9. Bae HM, Lee SH, Kim TM, Kim DW, Yang SC, Wu HG, Kim YW, Heo DS (2012) Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. Lung Cancer 77:572–577

    Article  PubMed  Google Scholar 

  10. Nakamura H, Ando K, Shinmyo T, Morita K, Mochizuki A, Kurimoto N, Tatsunami S (2011) Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis. Ann Thorac Cardiovasc Surg 17:469–480

    Article  PubMed  Google Scholar 

  11. Schirrmeister H, Arslandemir C, Glatting G, Mayer-Steinacker R, Bommer M, Dreinhofer K, Buck A, Hetzel M (2004) Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 31:964–968

    Article  PubMed  Google Scholar 

  12. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751

    Article  CAS  PubMed  Google Scholar 

  13. Hanibuchi M, Kim SJ, Fidler IJ, Nishioka Y (2014) The molecular biology of lung cancer brain metastasis: an overview of current comprehensions and future perspectives. J Med Invest 61:241–253

    Article  PubMed  Google Scholar 

  14. Dinnes J, Bancos I, Ferrante di Ruffano L, Chortis V, Davenport C, Bayliss S, Sahdev A, Guest P, Fassnacht M, Deeks JJ, Arlt W (2016) MANAGEMENT OF ENDOCRINE DISEASE: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis. Eur J Endocrinol 175:R51–R64

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Stenbygaard LE, Sorensen JB, Larsen H, Dombernowsky P (1999) Metastatic pattern in non-resectable non-small cell lung cancer. Acta Oncol 38:993–998

    Article  CAS  PubMed  Google Scholar 

  16. Kagohashi K, Satoh H, Ishikawa H, Ohtsuka M, Sekizawa K (2003) Liver metastasis at the time of initial diagnosis of lung cancer. Med Oncol 20:25–28

    Article  PubMed  Google Scholar 

  17. D’Souza MM, Sharma R, Mondal A, Jaimini A, Tripathi M, Saw SK, Singh D, Mishra A, Tripathi RP (2009) Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases. Nucl Med Commun 30:117–125

    Article  PubMed  Google Scholar 

  18. Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF (2000) FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 175:245–249

    Article  CAS  PubMed  Google Scholar 

  19. Schaffler GJ, Wolf G, Schoellnast H, Groell R, Maier A, Smolle-Juttner FM, Woltsche M, Fasching G, Nicoletti R, Aigner RM (2004) Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET. Radiology 231:858–865

    Article  PubMed  Google Scholar 

  20. Herder GJ, Kramer H, Hoekstra OS, Smit EF, Pruim J, van Tinteren H, Comans EF, Verboom P, Uyl-de Groot CA, Welling A, Paul MA, Boers M, Postmus PE, Teule GJ, Groen HJ, POORT Study Group (2006) Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol 24:1800–1806

    Article  PubMed  Google Scholar 

  21. Viney RC, Boyer MJ, King MT, Kenny PM, Pollicino CA, McLean JM, McCaughan BC, Fulham MJ (2004) Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol 22:2357–2362

    Article  PubMed  Google Scholar 

  22. Maziak DE, Darling GE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, Miller JD, Gu CS, Cline KJ, Evans WK, Levine MN (2009) Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 151:221–8, W-248

    Article  PubMed  Google Scholar 

  23. Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, Ravn J, Clementsen P, Hogholm A, Larsen K, Rasmussen T, Keiding S, Dirksen A, Gerke O, Skov B, Steffensen I, Hansen H, Vilmann P, Jacobsen G, Backer V, Maltbaek N, Pedersen J, Madsen H, Nielsen H, Hojgaard L (2009) Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 361:32–39

    Article  CAS  PubMed  Google Scholar 

  24. MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, Wirth A, Ware RE, Ball DL (2001) High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 50:287–293

    Article  CAS  PubMed  Google Scholar 

  25. Reed CE, Harpole DH, Posther KE, Woolson SL, Downey RJ, Meyers BF, Heelan RT, MacApinlac HA, Jung SH, Silvestri GA, Siegel BA, Rusch VW, American College of Surgeons Oncology Group Z0050 Trial (2003) Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126:1943–1951

    Article  PubMed  Google Scholar 

  26. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507

    Article  PubMed  Google Scholar 

  27. Kozower BD, Meyers BF, Reed CE, Jones DR, Decker PA, Putnam JB Jr (2008) Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer? Ann Thorac Surg 85:1166–1169; discussion 1169–1170.

    Article  PubMed  Google Scholar 

  28. De Wever W, Ceyssens S, Mortelmans L, Stroobants S, Marchal G, Bogaert J, Verschakelen JA (2007) Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol 17:23–32

    Article  PubMed  Google Scholar 

  29. Carnio S, Novello S, Papotti M, Loiacono M, Scagliotti GV (2013) Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures. Transl Lung Cancer Res 2:372–381

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Jimenez-Bonilla JF, Quirce R, Martinez-Rodriguez I, Banzo I, Rubio-Vassallo AS, Del Castillo-Matos R, Ortega-Nava F, Martinez-Amador N, Ibanez-Bravo S, Carril JM (2013) Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT. Lung Cancer 81:71–76

    Article  PubMed  Google Scholar 

  31. Liu J, Dong M, Sun X, Li W, Xing L, Yu J (2016) Prognostic value of 18F-FDG PET/CT in surgical non-small cell lung cancer: a meta-analysis. PLoS One 11:e0146195

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Ito R, Iwano S, Kishimoto M, Ito S, Kato K, Naganawa S (2015) Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma? Ann Nucl Med 29:897–905

    Article  CAS  PubMed  Google Scholar 

  33. Chaft JE, Dunphy M, Naidoo J, Travis WD, Hellmann M, Woo K, Downey R, Rusch V, Ginsberg MS, Azzoli CG, Kris MG (2016) Adaptive neoadjuvant chemotherapy guided by (18)F-FDG PET in resectable non-small cell lung cancers: the NEOSCAN trial. J Thorac Oncol 11:537–544

    Article  PubMed  Google Scholar 

  34. Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, Lutolf UM, Steinert HC, Von Schulthess GK (2003) Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 57:853–863

    Article  PubMed  Google Scholar 

  35. Erdi YE, Rosenzweig K, Erdi AK, Macapinlac HA, Hu YC, Braban LE, Humm JL, Squire OD, Chui CS, Larson SM, Yorke ED (2002) Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62:51–60

    Article  PubMed  Google Scholar 

  36. Hellwig D, Baum RP, Kirsch C (2009) FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review. Nuklearmedizin 48:59–69, quiz N58–59.

    Article  CAS  PubMed  Google Scholar 

  37. De Wever W, Stroobants S, Coolen J, Verschakelen JA (2009) Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration. Eur Respir J 33:201–212

    Article  PubMed  Google Scholar 

  38. Rosenzweig KE, Sura S, Jackson A, Yorke E (2007) Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol 25:5557–5561

    Article  PubMed  Google Scholar 

  39. Grills IS, Hope AJ, Guckenberger M, Kestin LL, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Wilbert J, Xiao Y, Belderbos J (2012) A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol 7:1382–1393

    Article  PubMed  Google Scholar 

  40. Aerts HJ, van Baardwijk AA, Petit SF, Offermann C, Loon J, Houben R, Dingemans AM, Wanders R, Boersma L, Borger J, Bootsma G, Geraedts W, Pitz C, Simons J, Wouters BG, Oellers M, Lambin P, Bosmans G, Dekker AL, De Ruysscher D (2009) Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. Radiother Oncol 91:386–392

    Article  PubMed  PubMed Central  Google Scholar 

  41. Larici AR, del Ciello A, Maggi F, Santoro SI, Meduri B, Valentini V, Giordano A, Bonomo L (2011) Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer. Radiographics 31:771–789

    Article  PubMed  Google Scholar 

  42. William WN Jr, Pataer A, Kalhor N, Correa AM, Rice DC, Wistuba II, Heymach J, Lee JJ, Kim ES, Munden R, Gold KA, Papadimitrakopoulou V, Swisher SG, Erasmus JJ, University of Texas M.D. Anderson Lung Cancer Collaborative Research Group (2013) Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy. J Thorac Oncol 8:222–228

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. van Loon J, Grutters JP, Wanders R, Boersma L, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Simons J, Brans B, Snoep G, Hochstenbag M, Lambin P, De Ruysscher D (2010) 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation. Eur J Cancer 46:110–119

    Article  PubMed  Google Scholar 

  44. de Cabanyes Candela S, Detterbeck FC (2010) A systematic review of restaging after induction therapy for stage IIIa lung cancer: prediction of pathologic stage. J Thorac Oncol 5:389–398

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Shanghai Chest Hospital, Shanghai, P. R. China

    Liu Liu, Maomei Ruan & Wenhui Xie

Authors
  1. Liu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maomei Ruan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenhui Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, China

    Gang Huang

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd. and Shanghai Jiao Tong University Press

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Liu, L., Ruan, M., Xie, W. (2019). Using 18F-FDG PET/CT to Diagnose and Treat Non-small Cell Lung Cancer. In: Huang, G. (eds) Nuclear Medicine in Oncology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7458-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7458-6_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7457-9

  • Online ISBN: 978-981-13-7458-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation